Kurtis Sarafin1, Ramón Durazo-Arvizu2, Lu Tian3, Karen W Phinney4, Susan Tai5, Johanna E Camara5, Joyce Merkel6, Evan Green7, Christopher T Sempos6, Stephen P J Brooks8. 1. Bureau of Nutritional Sciences, Health Canada, Ottawa, Canada; 2. Department of Public Health Sciences, Loyola University of Chicago Stritch School of Medicine, Chicago, IL; 3. Department of Health Research and Policy, Stanford University School of Medicine, Palo Alto, CA; 4. Biomolecular Measurement Division and. 5. Chemical Sciences Division, National Institute of Standards and Technology, Gaithersburg, MD; 6. NIH, Office of Dietary Supplements, Bethesda, MD; and. 7. Statistics Canada, Ottawa, Canada. 8. Bureau of Nutritional Sciences, Health Canada, Ottawa, Canada; steve.brooks@hc-sc.gc.ca.
Abstract
BACKGROUND: The Canadian Health Measures Survey (CHMS) is an ongoing cross-sectional national survey that includes a measure of 25-hydroxyvitamin D [25(OH)D] by immunoassay. For cycles 1 and 2, the collection period occurred approximately every 2 y, with a new sample of ∼5600 individuals. OBJECTIVE: The goal was to standardize the original 25(OH)D CHMS values in cycles 1 and 2 to the internationally recognized reference measurement procedures (RMPs) developed by the US National Institute for Standards and Technology (NIST) and Ghent University, Belgium. DESIGN: Standardization was accomplished by using a 2-step procedure. First, serum samples corresponding to the original plasma samples were remeasured by using the currently available immunoassay method. Second, 50 serum samples with known 25(OH)D values assigned by the NIST and Ghent reference method laboratories were measured by using the currently available immunoassay method. The mathematical models for each step-i.e., 1) YCurrent = XOriginal and 2) YNIST-Ghent = XCurrent -were estimated by using Deming regression, and the 2 models were solved to obtain a single equation for converting the "original" values to NIST-Ghent RMP values. RESULTS: After standardization (cycles 1 and 2 combined), the percentage of Canadians with 25(OH)D values <40 nmol/L increased from 16.4% (original) to 19.4% (standardized), and values <50 nmol/L increased from 29.0% (original) to 36.8% (standardized). The 25(OH)D standardized distributions (cycles 1 and 2 analyzed separately) were similar across age and sex groups; slightly higher values were associated with cycle 2 in the young and old. This finding contrasts with the original data, which indicated that cycle 2 values were lower for all age groups. CONCLUSION: The shifts in 25(OH)D distribution brought about by standardization indicate its importance in drawing correct conclusions about potential population deficiencies and insufficiencies and in permitting the comparison of distributions between national surveys.
BACKGROUND: The Canadian Health Measures Survey (CHMS) is an ongoing cross-sectional national survey that includes a measure of 25-hydroxyvitamin D [25(OH)D] by immunoassay. For cycles 1 and 2, the collection period occurred approximately every 2 y, with a new sample of ∼5600 individuals. OBJECTIVE: The goal was to standardize the original 25(OH)D CHMS values in cycles 1 and 2 to the internationally recognized reference measurement procedures (RMPs) developed by the US National Institute for Standards and Technology (NIST) and Ghent University, Belgium. DESIGN: Standardization was accomplished by using a 2-step procedure. First, serum samples corresponding to the original plasma samples were remeasured by using the currently available immunoassay method. Second, 50 serum samples with known 25(OH)D values assigned by the NIST and Ghent reference method laboratories were measured by using the currently available immunoassay method. The mathematical models for each step-i.e., 1) YCurrent = XOriginal and 2) YNIST-Ghent = XCurrent -were estimated by using Deming regression, and the 2 models were solved to obtain a single equation for converting the "original" values to NIST-Ghent RMP values. RESULTS: After standardization (cycles 1 and 2 combined), the percentage of Canadians with 25(OH)D values <40 nmol/L increased from 16.4% (original) to 19.4% (standardized), and values <50 nmol/L increased from 29.0% (original) to 36.8% (standardized). The 25(OH)D standardized distributions (cycles 1 and 2 analyzed separately) were similar across age and sex groups; slightly higher values were associated with cycle 2 in the young and old. This finding contrasts with the original data, which indicated that cycle 2 values were lower for all age groups. CONCLUSION: The shifts in 25(OH)D distribution brought about by standardization indicate its importance in drawing correct conclusions about potential population deficiencies and insufficiencies and in permitting the comparison of distributions between national surveys.
Authors: Christine L Taylor; Alicia L Carriquiry; Regan L Bailey; Christopher T Sempos; Elizabeth A Yetley Journal: Am J Clin Nutr Date: 2012-10-24 Impact factor: 7.045
Authors: Kevin D Cashman; Mairead Kiely; Michael Kinsella; Ramón A Durazo-Arvizu; Lu Tian; Yue Zhang; Alice Lucey; Albert Flynn; Michael J Gibney; Hubert W Vesper; Karen W Phinney; Paul M Coates; Mary F Picciano; Christopher T Sempos Journal: Am J Clin Nutr Date: 2013-04-24 Impact factor: 7.045
Authors: Lu Tian; Ramón A Durazo-Arvizu; Gary Myers; Steve Brooks; Kurtis Sarafin; Christopher T Sempos Journal: Stat Med Date: 2014-06-17 Impact factor: 2.373
Authors: Susan J Whiting; Kellie A Langlois; Hassanali Vatanparast; Linda S Greene-Finestone Journal: Am J Clin Nutr Date: 2011-05-18 Impact factor: 7.045
Authors: Kevin D Cashman; Aoife Hayes; Karen Galvin; Joyce Merkel; Glenville Jones; Martin Kaufmann; Andrew N Hoofnagle; Graham D Carter; Ramon A Durazo-Arvizu; Christopher T Sempos Journal: Clin Chem Date: 2015-02-20 Impact factor: 8.327
Authors: Ramon A Durazo-Arvizu; Pauline Camacho; Pascal Bovet; Terrence Forrester; Estelle V Lambert; Jacob Plange-Rhule; Andrew N Hoofnagle; John Aloia; Bamidele Tayo; Lara R Dugas; Richard S Cooper; Amy Luke Journal: Am J Clin Nutr Date: 2014-07-09 Impact factor: 7.045
Authors: Kevin D Cashman; Ellen Ghm van den Heuvel; Ruud Jw Schoemaker; Damien P Prévéraud; Helen M Macdonald; Jayashree Arcot Journal: Adv Nutr Date: 2017-11-15 Impact factor: 8.701
Authors: Ramón A Durazo-Arvizu; Bess Dawson-Hughes; Holly Kramer; Guichan Cao; Joyce Merkel; Paul M Coates; Christopher T Sempos Journal: Am J Epidemiol Date: 2017-04-15 Impact factor: 4.897
Authors: Saleh M Al-Qahtani; Ayed A Shati; Youssef A Alqahtani; Samy A Dawood; Aesha F Siddiqui; Mohamed Samir A Zaki; Shamsun N Khalil Journal: Healthcare (Basel) Date: 2022-06-08
Authors: Konstantinos Makris; Harjit P Bhattoa; Etienne Cavalier; Karen Phinney; Christopher T Sempos; Candice Z Ulmer; Samuel D Vasikaran; Hubert Vesper; Annemieke C Heijboer Journal: Clin Chim Acta Date: 2021-03-10 Impact factor: 6.314
Authors: Linda S Greene-Finestone; Didier Garriguet; Stephen Brooks; Kellie Langlois; Susan J Whiting Journal: Paediatr Child Health Date: 2017-11-10 Impact factor: 2.253